{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:51:27Z","timestamp":1791517887047,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05551-7","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:06:28Z","timestamp":1784117188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbiome and peptide alterations in children with acute lymphoblastic leukemia: current insights and future directions"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7595-5459","authenticated-orcid":false,"given":"Zuzanna","family":"Zakrzewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0976-0141","authenticated-orcid":false,"given":"Oliwia","family":"Boruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6714-7410","authenticated-orcid":false,"given":"Dominika","family":"Skupie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6867-2717","authenticated-orcid":false,"given":"Szymon","family":"Skocze\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"5551_CR1","first-page":"1","volume":"3","author":"B Emily","year":"2015","unstructured":"Emily B, Hollister, et al. Structure and function of the healthy preadolescent pediatric gut microbiome. Microbiome. 2015;3:1\u201313.","journal-title":"Microbiome"},{"key":"5551_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","volume":"569","author":"The Integrative Human Microbiome Project. In","year":"2019","unstructured":"The Integrative Human Microbiome Project. In. Nature. 2019;569:641\u20138.","journal-title":"Nature"},{"key":"5551_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nm.4185","volume":"22","author":"O Bjoern","year":"2016","unstructured":"Bjoern O, Schroeder and Fredrik B\u00a8ackhed. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22:1079\u201389.","journal-title":"Nat Med"},{"issue":"1","key":"5551_CR4","doi-asserted-by":"publisher","first-page":"18880","DOI":"10.1038\/s41598-019-55290-9","volume":"9","author":"K-D Kinga","year":"2019","unstructured":"Kinga K-D, et al. Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn\u2019s disease. Sci Rep. 2019;9(1):18880.","journal-title":"Sci Rep"},{"key":"5551_CR5","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"Morgan Xc","year":"2012","unstructured":"Morgan Xc. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.","journal-title":"Genome Biol"},{"key":"5551_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"Q Junjie","year":"2012","unstructured":"Junjie Q, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55\u201360.","journal-title":"Nature"},{"key":"5551_CR7","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.humic.2019.100069","volume":"15","author":"V-A Katerina","year":"2020","unstructured":"Katerina V-A, Johnson. Gut microbiome composition and diversity are related to human personality traits. Hum Microbiome J. 2020;15:100069.","journal-title":"Hum Microbiome J"},{"key":"5551_CR8","first-page":"1451","volume":"155","author":"Y Elaine","year":"2013","unstructured":"Elaine Y, Hsiao, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. In: Cell. 2013;155:1451\u201363.","journal-title":"In: Cell"},{"key":"5551_CR9","first-page":"97417","volume":"6","author":"MH James","year":"2014","unstructured":"James MH, et al. Pathogenic microbes, the microbiome, and Alzheimer\u2019s disease (AD). Front Aging Neurosci. 2014;6:97417.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"5551_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/cancers13040734","volume":"13","author":"Y Gwangbeom Heo","year":"2021","unstructured":"Gwangbeom Heo Y, Lee, Im E. Interplay between the gut microbiota and inflammatory mediators in the development of colorectal cancer. Cancers. 2021;13(4):734.","journal-title":"Cancers"},{"key":"5551_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"S Wendy","year":"2015","unstructured":"Wendy S, Garrett. Cancer and the microbiota. Science. 2015;348:80\u20136.","journal-title":"Science"},{"issue":"2","key":"5551_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/carcin\/bgt392","volume":"35","author":"JB Scott","year":"2014","unstructured":"Scott JB. Emerging roles of the microbiome in cancer. Carcinogenesis. 2014;35(2):249\u201355.","journal-title":"Carcinogenesis"},{"issue":"1","key":"5551_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12941-024-00717-z","volume":"23","author":"Huidi","year":"2024","unstructured":"Huidi, Wang, et al. Microbial metagenomic shifts in children with acute lymphoblastic leukaemia during induction therapy and predictive biomarkers for infection. Ann Clin Microbiol Antimicrob. 2024;23(1):52.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5551_CR14","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/ijc.32942","volume":"147","author":"Silvia","year":"2020","unstructured":"Silvia, De Pietri, et al. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota. Int J Cancer. 2020;147:1953\u201362.","journal-title":"Int J Cancer"},{"key":"5551_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-016-2965-y","volume":"17","author":"VR Seesandra","year":"2016","unstructured":"Seesandra VR, et al. Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis. BMC Genomics. 2016;17:1\u201310.","journal-title":"BMC Genomics"},{"key":"5551_CR16","doi-asserted-by":"publisher","first-page":"1437869","DOI":"10.3389\/fimmu.2024.1437869","volume":"15","author":"Z Xin","year":"2024","unstructured":"Xin Z, et al. Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites. Front Immunol. 2024;15:1437869.","journal-title":"Front Immunol"},{"key":"5551_CR17","doi-asserted-by":"publisher","first-page":"558799","DOI":"10.3389\/fcimb.2020.558799","volume":"10","author":"Xiaoming","year":"2020","unstructured":"Xiaoming, Liu, et al. Pediatric acute lymphoblastic leukemia patients exhibit distinctive alterations in the gut microbiota. Front Cell Infect Microbiol. 2020;10:558799.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"5551_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/bmt.2015.16","volume":"50","author":"ELENA Biagi","year":"2015","unstructured":"Biagi ELENA, et al. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant. 2015;50(7):992\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"5551_CR19","doi-asserted-by":"publisher","first-page":"924707","DOI":"10.3389\/fcimb.2022.924707","volume":"12","author":"AD Katherine","year":"2022","unstructured":"Katherine AD, et al. Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic defense. Front Cell Infect Microbiol. 2022;12:924707.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"5551_CR20","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1097\/INF.0b013e3181aa6eae","volume":"28","author":"A Samina","year":"2009","unstructured":"Samina A, et al. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia. Pediatr Infect Dis J. 2009;28(12):1064\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"5551_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2141.2005.05736.x","volume":"131","author":"SC Merete","year":"2005","unstructured":"Merete SC, et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992\u2013 2001. Br J Haematol. 2005;131(1):50\u20138.","journal-title":"Br J Haematol"},{"issue":"7","key":"5551_CR22","first-page":"1056","volume":"124","author":"O\u2019Connor David","year":"2014","unstructured":"David O\u2019Connor, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood J Am Soc Hematol. 2014;124(7):1056\u201361.","journal-title":"Blood J Am Soc Hematol"},{"key":"5551_CR23","doi-asserted-by":"publisher","first-page":"2333794X2090193","DOI":"10.1177\/2333794X20901930","volume":"7","author":"KH Tran","year":"2020","unstructured":"Tran KH, et al. Causes of death in childhood acute lymphoblastic leukemia at Hue Central Hospital for 10 years (2008\u20132018). Global Pediatr health. 2020;7:2333794X20901930.","journal-title":"Global Pediatr health"},{"issue":"2","key":"5551_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/annonc\/mdw557","volume":"28","author":"I Hiroto","year":"2017","unstructured":"Hiroto I, et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol. 2017;28(2):386\u201392.","journal-title":"Ann Oncol"},{"key":"5551_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fcimb.2019.00028","volume":"9","author":"TN Jacob","year":"2019","unstructured":"Jacob TN, et al. Infectious complications are associated with alterations in the gut microbiome in pediatric patients with acute lymphoblastic leukemia. Front Cell Infect Microbiol. 2019;9:28.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"5551_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/ciy153","volume":"67","author":"H Hana","year":"2018","unstructured":"Hana H, et al. Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clin Infect Dis. 2018;67(4):541\u20138.","journal-title":"Clin Infect Dis"},{"key":"5551_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08917-y","volume":"21","author":"Xiaoming","year":"2021","unstructured":"Xiaoming, Liu, et al. Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia. BMC Cancer. 2021;21:1\u20139.","journal-title":"BMC Cancer"},{"key":"5551_CR28","doi-asserted-by":"publisher","first-page":"1427185","DOI":"10.3389\/fped.2024.1427185","volume":"12","author":"Miroslava Simiakov\u00b4a and Viktor Bielik","year":"2024","unstructured":"Miroslava Simiakov\u00b4a and Viktor Bielik. The pros and cons of probiotic\u02c7 use in pediatric oncology patients following treatment for acute lymphoblastic leukemia. Front Pead. 2024;12:1427185.","journal-title":"Front Pead"},{"key":"5551_CR29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00520-009-0711-6","volume":"18","author":"W Mariko","year":"2010","unstructured":"Mariko W, et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer. 2010;18:751\u20139.","journal-title":"Support Care Cancer"},{"key":"5551_CR30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MPH.0000000000001497","volume":"41","author":"R-F Jesus","year":"2019","unstructured":"Jesus R-F, et al. Probiotic supplementation decreases chemotherapyinduced gastrointestinal side effects in patients with acute leukemia. J Pediatr Hematol Oncol. 2019;41:468\u201372.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"5551_CR31","doi-asserted-by":"publisher","first-page":"232470961774423","DOI":"10.1177\/2324709617744233","volume":"5","author":"A Paurush","year":"2017","unstructured":"Paurush A, et al. Recurrent Lactobacillus bacteremia in a patient with leukemia. J Investig Med High Impact Case Rep. 2017;5(4):2324709617744233.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"5551_CR32","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/microorganisms11040896","volume":"11","author":"K Ravina","year":"2023","unstructured":"Ravina K, et al. Lactobacillus bacteremia and probiotics: a review. Microorganisms. 2023;11:896.","journal-title":"Microorganisms"},{"key":"5551_CR33","doi-asserted-by":"crossref","unstructured":"Rafael Lessa Costa et al. Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series. BMC Complement Altern Med. 2018;18: 1\u20138.","DOI":"10.1186\/s12906-018-2394-3"},{"key":"5551_CR34","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s00248-019-01448-x","volume":"79","author":"VR Seesandra","year":"2020","unstructured":"Seesandra VR, et al. Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (ALL) during chemotherapy. Microb Ecol. 2020;79:1034\u201343.","journal-title":"Microb Ecol"},{"key":"5551_CR35","first-page":"1","volume":"20","author":"C Ling Ling","year":"2020","unstructured":"Ling Ling C, et al. Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement, during-, and post-cessation of chemotherapy. BMC Cancer. 2020;20:1\u201311.","journal-title":"BMC Cancer"},{"key":"5551_CR36","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.3390\/ijms23073712","volume":"23","author":"Konon\u00b4czuk Katarzyna","year":"2022","unstructured":"Katarzyna Konon\u00b4czuk, et al. Biomarkers of glucose metabolism alterations and the onset of metabolic syndrome in survivors of childhood acute lymphoblastic leukemia. Int J Mol Sci. 2022;23:3712.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5551_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/pbc.22964","volume":"58","author":"ST Emily","year":"2012","unstructured":"Emily ST, et al. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer. 2012;58(1):31\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"5551_CR38","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1097\/MPH.0b013e3181b8a50c","volume":"32","author":"M Maria","year":"2010","unstructured":"Maria M, et al. Serial plasma concentrations of adiponectin, leptin, and resistin during therapy in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2010;32(1):e8\u201313.","journal-title":"J Pediatr Hematol Oncol"},{"key":"5551_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3097-8","volume":"17","author":"B-C Lourdes","year":"2017","unstructured":"Lourdes B-C, et al. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country. BMC Cancer. 2017;17:1\u201313.","journal-title":"BMC Cancer"},{"key":"5551_CR40","first-page":"622","volume":"243","author":"GK Tyler","year":"2018","unstructured":"Tyler GK, et al. Adipokines, inflammation, and adiposity in hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant. 2018;243:622\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"5551_CR41","first-page":"504","volume":"42","author":"A Hatim","year":"2013","unstructured":"Hatim A, El-Baz, et al. Serum adiponectin and resistin levels in de novo and relapsed acute lymphoblastic leukemia children patients. Iran J public health. 2013;42:504.","journal-title":"Iran J public health"},{"issue":"1","key":"5551_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/10428194.2015.1063145","volume":"57","author":"Shahab Uddin","year":"2016","unstructured":"Shahab Uddin, Ramzi M, Mohammad. Role of leptin and leptin receptors in hematological malignancies. Leuk Lymphoma. 2016;57(1):10\u20136.","journal-title":"Leuk Lymphoma"},{"key":"5551_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/10428190009148392","volume":"36","author":"H Masayuki","year":"2000","unstructured":"Masayuki H, et al. Leptin receptor and leukemia. Leuk Lymphoma. 2000;36:457\u201361.","journal-title":"Leuk Lymphoma"},{"key":"5551_CR44","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/BF02982810","volume":"76","author":"W Heike","year":"2002","unstructured":"Heike W, et al. Plasma leptin and leptin receptor expression in childhood acute lymphoblastic leukemia. Int J Hematol. 2002;76:446\u201352.","journal-title":"Int J Hematol"},{"key":"5551_CR45","doi-asserted-by":"crossref","unstructured":"Gorska E, Popko K, Wasik M. Leptin receptor in childhood acute leukemias. Respiratory Regulation-The Molecular Approach. Springer; 2012: pp. 155\u201361.","DOI":"10.1007\/978-94-007-4549-0_20"},{"key":"5551_CR46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/MPH.0b013e318179a1d8","volume":"30","author":"M Maria","year":"2008","unstructured":"Maria M, et al. Serial plasma concentrations of PYY and ghrelin during chemotherapy in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008;30:733\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"5551_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1590\/1516-3180.2019.0307.r1.19112019","volume":"138","author":"CC Gomes","year":"2020","unstructured":"Gomes CC, et al. Nutritional status and appetite-regulating hormones in early treatment of acute lymphoblastic leukemia among children and adolescents: a cohort study. Sao Paulo Med J. 2020;138(2):118\u201325. https:\/\/doi.org\/10.1590\/1516-3180.2019.0307.r1.19112019.","journal-title":"Sao Paulo Med J"},{"issue":"8","key":"5551_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Van Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461\u201378. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"5551_CR49","doi-asserted-by":"publisher","first-page":"2414796","DOI":"10.1080\/19490976.2024.2414796","volume":"16","author":"M Yu","year":"2024","unstructured":"Yu M, Yu B, Chen D. The effects of gut microbiota on appetite regulation and the underlying mechanisms. Gut Microbes. 2024;16(1):2414796. https:\/\/doi.org\/10.1080\/19490976.2024.2414796","journal-title":"Gut Microbes"},{"key":"5551_CR50","doi-asserted-by":"publisher","first-page":"1290505","DOI":"10.3389\/fonc.2023.1290505","volume":"13","author":"Maria Perp\u00b4etuo Socorro Sampaio Carvalho","year":"2023","unstructured":"Maria Perp\u00b4etuo Socorro Sampaio Carvalho. Systemic immunological profile of children with B-cell acute lymphoblastic leukemia: performance of cell populations and soluble mediators as serum biomarkers. Front Oncol. 2023;13:1290505.","journal-title":"Front Oncol"},{"key":"5551_CR51","unstructured":"Chul Hwan K, et al. Nov. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med. 2023."},{"key":"5551_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"S Liang","year":"2023","unstructured":"Liang S, Su Y. T cells in health and disease. Signal Transduct Target Therapy. 2023;8:235. https:\/\/doi.org\/10.1038\/s41392-023-01471-y.","journal-title":"Signal Transduct Target Therapy"},{"key":"5551_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-immunol-070119-115104","volume":"38","author":"H Kayama","year":"2020","unstructured":"Kayama H, Okumura R, Takeda K. Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine. Annu Rev Immunol. 2020;38:23\u201348. 10.1146\/ annurev-immunol-070119-115104.","journal-title":"Annu Rev Immunol"},{"key":"5551_CR54","doi-asserted-by":"publisher","first-page":"1185787","DOI":"10.3389\/fmicb.2023.1185787","volume":"14","author":"G-R Pamela","year":"2023","unstructured":"Pamela G-R, et al. Role of the gut microbiota in hematologic cancer. Front Microbiol. 2023;14:1185787. https:\/\/doi.org\/10.3389\/fmicb.2023.1185787","journal-title":"Front Microbiol"},{"key":"5551_CR55","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41568-023-00584-4","volume":"23","author":"P Ioannis","year":"2023","unstructured":"Ioannis P, et al. Gut microbiome immaturity and childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2023;23:565\u201376. https:\/\/doi.org\/10.1038\/s41568-023-00584-4.","journal-title":"Nat Rev Cancer"},{"key":"5551_CR56","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-18-0831","volume":"78","author":"S\u00f8egaard Signe Holst","year":"2018","unstructured":"Signe Holst S\u00f8egaard, et al. Neonatal inflammatory markers are associated with childhood B-cell precursor acute lymphoblastic leukemia. Cancer Res. 2018;78:5458\u201363.","journal-title":"Cancer Res"},{"key":"5551_CR57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/1055-9965.DISP-11-B8","volume":"20","author":"SC Jeffrey","year":"2011","unstructured":"Jeffrey SC, et al. Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2011;20:8.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5551_CR58","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1158\/1055-9965.EPI-20-1704","volume":"30","author":"PW Todd","year":"2021","unstructured":"Todd PW, et al. Cytokine levels at birth in children who developed acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2021;30:1526\u201335.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5551_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-017-0250-1","volume":"5","author":"LC Ling","year":"2017","unstructured":"Ling LC, et al. Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome. 2017;5:1\u201314.","journal-title":"Microbiome"},{"issue":"7","key":"5551_CR60","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.3390\/ijms25073928","volume":"25","author":"TS Aronica","year":"2024","unstructured":"Aronica TS, Carella M, Carmela Rita Balistreri. Different levels of therapeutic strategies to recover the microbiome to prevent\/delay acute lymphoblastic leukemia (ALL) or arrest its progression in children. Int J Mol Sci. 2024;25(7):3928.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5551_CR61","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1158\/1055-9965.EPI-17-0778","volume":"27","author":"LM Erin","year":"2018","unstructured":"Erin LM, et al. Cesarean delivery and risk of infant Leukemia: a report from the children\u2019s oncology group. Cancer Epidemiol Biomarkers Prev. 2018;27(4):473\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5551_CR62","first-page":"2003","volume":"136","author":"V-D Carolina","year":"2020","unstructured":"Carolina V-D, et al. An intact gut microbiome protects genetically predisposed mice against leukemia. Blood J Am Soc Hematol. 2020;136:2003\u201317.","journal-title":"Blood J Am Soc Hematol"},{"issue":"4","key":"5551_CR63","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/003335490912400407","volume":"124","author":"LK Marilyn","year":"2009","unstructured":"Marilyn LK, et al. Maternal diet and risk of childhood acute lymphoblastic leukemia. Public Health Rep. 2009;124(4):503\u201314.","journal-title":"Public Health Rep"},{"key":"5551_CR64","doi-asserted-by":"publisher","unstructured":"Sabrina B, Todor IC. Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review. Children (Basel). 2025. https:\/\/doi.org\/10.3390\/children12020166","DOI":"10.3390\/children12020166"},{"key":"5551_CR65","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5603\/ahp.","volume":"54","author":"I Agnieszka","year":"2023","unstructured":"Agnieszka I, Fa lkowska, et al. Safe use of fecal microbiota transplant in treatment of graft versus host disease in a 5-year-old child. Acta Haematol Pol. 2023;54:266\u20138. https:\/\/doi.org\/10.5603\/ahp.","journal-title":"Acta Haematol Pol"},{"key":"5551_CR66","doi-asserted-by":"crossref","unstructured":"Senthilkumar A et al. Jan. CAR-T Cell Therapy and the Gut Microbiota. In: Cancers (Basel) 15.3 (2023), p. 794. 10.3390\/ cancers15030794","DOI":"10.3390\/cancers15030794"},{"key":"5551_CR67","doi-asserted-by":"publisher","first-page":"1362133","DOI":"10.3389\/fimmu.2024.1362133","volume":"15","author":"P Zhang","year":"2024","unstructured":"Zhang P, Xie D Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope? Front Immunol. 2024;15:1362133. https:\/\/doi.org\/10.3389\/fimmu.2024.1362133.","journal-title":"Front Immunol"},{"key":"5551_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02234-6","author":"K Carola","year":"2023","unstructured":"Carola K, Stein-Thoeringer, et al. Apr. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat Med. 2023 https:\/\/doi.org\/10.1038\/s41591-023-02234-6","journal-title":"Nat Med"},{"issue":"11","key":"5551_CR69","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1038\/s41591-022-02069-7","volume":"29","author":"S Matthew","year":"2023","unstructured":"Matthew S, et al. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. In: Nature Medicine 28.4 (Apr. 2022). Epub 2022; Erratum in. Nat Med. 2023;29(11):2954. https:\/\/doi.org\/10.1038\/s41591-022-02069-7.","journal-title":"Nat Med"},{"key":"5551_CR70","first-page":"e944687","volume":"25","author":"Osamu Imataki and Makiko Uemura","year":"2024","unstructured":"Osamu Imataki and Makiko Uemura. Bifidobacterium Bloodstream Infection in a Lymphoma Patient Undergoing Chemotherapy: A Case Study and Implications for Probiotic Use. Am J Case Rep. 2024;25:e944687.","journal-title":"Am J Case Rep"},{"issue":"2","key":"5551_CR71","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2468-1253(24)00311-X","volume":"10","author":"P Serena","year":"2025","unstructured":"Serena P, et al. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterol Hepatol. 2025;10(2):154\u201367.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5551_CR72","doi-asserted-by":"publisher","first-page":"e70019","DOI":"10.1111\/exd.70019","volume":"33","author":"M Tushar","year":"2024","unstructured":"Tushar M, et al. Advances in Microbiome-Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions. Exp Dermatol. 2024;33:e70019.","journal-title":"Exp Dermatol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05551-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:45:14Z","timestamp":1791517514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05551-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5551"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05551-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1418"}}